The Lifespan/Tufts/Brown CFAR was established in 1998 as a collaboration between Brown University and Tufts University and their affiliated hospitals. Since the Initial CFAR award in 1998, we have successfully competed for two renewals, and met our stated benchmarks and milestones throughout the 12 years since the Initial award. We have revised our goals as the epidemic and its treatment have evolved, and steadily increased the interdisciplinary research essential to further progress in this area. This CFAR serves as the basis for extensive collaborative, interdisciplinary research among the CFAR members, and has served as the leading force in developing and supporting relevant new initiatives. This application emphasizes the return on investment of funding cross-disciplinary HIV research throughout Brown and Tufts Universities, their affiliated hospitals, and partner institutions in the developing world. In accordance with directives in the NIH CFAR PAR, we have developed a multidisciplinary environment that supports basic, clinical, epidemiologic, behavioral and translational research in the detection, prevention, and treatment of HIV infection and AIDS. This application emphasizes our progress toward this mission over the past four years, and its proposed activities over the next five years. If this application proves to be successful. Looking ahead, we Intend to further emphasize multi-institutional, cross-disciplinary studies related to HIV/AIDS both in New England and In Sub-Saharan Africa and Asia, with continuing support for our established CFAR Scientific Programs In International HIV/AIDS and in Prisoner Health and Human Rights for cross-disciplinary work In our Scientific Working Groups related to neurocognitive aspects of HIV and its treatment, cardiovascular and metabolic consequences of HIV and antiretroviral therapy In our aging population of persons living with HIV, and further multidisciplinary studies of the consequences of alcohol and other substances of abuse on HIV acquisition and response to treatment.

Public Health Relevance

Despite advances In HIV/AIDS treatment and prevention, the disease continues to ravage many lives. Our CFARs ultimate goal is to Improve the lives of people living with HIV and prevent new Infections by serving as a basis for extensive collaborative, multi and Interdisciplinary research. The development of junior investigators within the field is crucial to stemming this epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-17
Application #
8685864
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Namkung, Ann S
Project Start
1998-09-01
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
17
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02906
Stone, Andrew C; Carroll, Jennifer J; Rich, Josiah D et al. (2018) Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug Alcohol Depend 192:94-97
Chan, Philip A; Montgomery, Madeline C; Rose, Jennifer et al. (2018) Statewide Evaluation of New HIV Diagnoses in Rhode Island: Implications for Prevention. Public Health Rep 133:489-496
Akiyama, Hisashi; Miller, Caitlin M; Ettinger, Chelsea R et al. (2018) HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction. Nat Commun 9:3450
Dong, Kimberly R; Must, Aviva; Tang, Alice M et al. (2018) Food Insecurity, Morbidities, and Substance Use in Adults on Probation in Rhode Island. J Urban Health 95:564-575
Skeer, Margie R; Ladin, Keren; Wilkins, Lindsay E et al. (2018) 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Drug Alcohol Depend 190:246-254
Ma, Y; Horsburgh, C R; White, L F et al. (2018) Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis. Epidemiol Infect 146:1478-1494
Wurcel, Alysse G; Burke, Deirdre; Skeer, Margie et al. (2018) Sex work, injection drug use, and abscesses: Associations in women, but not men. Drug Alcohol Depend 185:293-297
Dompreh, Albert; Tang, Xiaoli; Zhou, Jianlin et al. (2018) Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrob Agents Chemother 62:
Schackman, Bruce R; Gutkind, Sarah; Morgan, Jake R et al. (2018) Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug Alcohol Depend 185:411-420
Adams, Joƫlla W; Bryant, Kendall J; Edelman, Jennifer E et al. (2018) Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men. AIDS Behav 22:1341-1351

Showing the most recent 10 out of 806 publications